Toll Free: 1-888-928-9744
Published: Oct, 2018 | Pages:
91 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)
In 2017, the global Microbiome Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. This report focuses on the global Microbiome Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Microbiome Drugs development in United States, Europe and China. The key players covered in this study Pfizer Second Genome Seres Therapeutics MaaT Pharma Enterome Bioscience MicroBiome Therapeutics Ritter Pharmaceuticals Rebiotix OpenBiome Market segment by Type, the product can be split into Probiotics Prebiotics Small Molecules Biological Drugs Other Market segment by Application, split into Hospital Pharmacies Retail Pharmacies Online Pharmacies Other Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Microbiome Drugs status, future forecast, growth opportunity, key market and key players. To present the Microbiome Drugs development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Microbiome Drugs are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Microbiome Drugs Market Size Growth Rate by Type (2013-2025) 1.4.2 Probiotics 1.4.3 Prebiotics 1.4.4 Small Molecules 1.4.5 Biological Drugs 1.4.6 Other 1.5 Market by Application 1.5.1 Global Microbiome Drugs Market Share by Application (2013-2025) 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.5.5 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Microbiome Drugs Market Size 2.2 Microbiome Drugs Growth Trends by Regions 2.2.1 Microbiome Drugs Market Size by Regions (2013-2025) 2.2.2 Microbiome Drugs Market Share by Regions (2013-2018) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Microbiome Drugs Market Size by Manufacturers 3.1.1 Global Microbiome Drugs Revenue by Manufacturers (2013-2018) 3.1.2 Global Microbiome Drugs Revenue Market Share by Manufacturers (2013-2018) 3.1.3 Global Microbiome Drugs Market Concentration Ratio (CR5 and HHI) 3.2 Microbiome Drugs Key Players Head office and Area Served 3.3 Key Players Microbiome Drugs Product/Solution/Service 3.4 Date of Enter into Microbiome Drugs Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Microbiome Drugs Market Size by Type (2013-2018) 4.2 Global Microbiome Drugs Market Size by Application (2013-2018) 5 United States 5.1 United States Microbiome Drugs Market Size (2013-2018) 5.2 Microbiome Drugs Key Players in United States 5.3 United States Microbiome Drugs Market Size by Type 5.4 United States Microbiome Drugs Market Size by Application 6 Europe 6.1 Europe Microbiome Drugs Market Size (2013-2018) 6.2 Microbiome Drugs Key Players in Europe 6.3 Europe Microbiome Drugs Market Size by Type 6.4 Europe Microbiome Drugs Market Size by Application 7 China 7.1 China Microbiome Drugs Market Size (2013-2018) 7.2 Microbiome Drugs Key Players in China 7.3 China Microbiome Drugs Market Size by Type 7.4 China Microbiome Drugs Market Size by Application 8 Japan 8.1 Japan Microbiome Drugs Market Size (2013-2018) 8.2 Microbiome Drugs Key Players in Japan 8.3 Japan Microbiome Drugs Market Size by Type 8.4 Japan Microbiome Drugs Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Microbiome Drugs Market Size (2013-2018) 9.2 Microbiome Drugs Key Players in Southeast Asia 9.3 Southeast Asia Microbiome Drugs Market Size by Type 9.4 Southeast Asia Microbiome Drugs Market Size by Application 10 India 10.1 India Microbiome Drugs Market Size (2013-2018) 10.2 Microbiome Drugs Key Players in India 10.3 India Microbiome Drugs Market Size by Type 10.4 India Microbiome Drugs Market Size by Application 11 Central & South America 11.1 Central & South America Microbiome Drugs Market Size (2013-2018) 11.2 Microbiome Drugs Key Players in Central & South America 11.3 Central & South America Microbiome Drugs Market Size by Type 11.4 Central & South America Microbiome Drugs Market Size by Application 12 International Players Profiles 12.1 Pfizer 12.1.1 Pfizer Company Details 12.1.2 Company Description and Business Overview 12.1.3 Microbiome Drugs Introduction 12.1.4 Pfizer Revenue in Microbiome Drugs Business (2013-2018) 12.1.5 Pfizer Recent Development 12.2 Second Genome 12.2.1 Second Genome Company Details 12.2.2 Company Description and Business Overview 12.2.3 Microbiome Drugs Introduction 12.2.4 Second Genome Revenue in Microbiome Drugs Business (2013-2018) 12.2.5 Second Genome Recent Development 12.3 Seres Therapeutics 12.3.1 Seres Therapeutics Company Details 12.3.2 Company Description and Business Overview 12.3.3 Microbiome Drugs Introduction 12.3.4 Seres Therapeutics Revenue in Microbiome Drugs Business (2013-2018) 12.3.5 Seres Therapeutics Recent Development 12.4 MaaT Pharma 12.4.1 MaaT Pharma Company Details 12.4.2 Company Description and Business Overview 12.4.3 Microbiome Drugs Introduction 12.4.4 MaaT Pharma Revenue in Microbiome Drugs Business (2013-2018) 12.4.5 MaaT Pharma Recent Development 12.5 Enterome Bioscience 12.5.1 Enterome Bioscience Company Details 12.5.2 Company Description and Business Overview 12.5.3 Microbiome Drugs Introduction 12.5.4 Enterome Bioscience Revenue in Microbiome Drugs Business (2013-2018) 12.5.5 Enterome Bioscience Recent Development 12.6 MicroBiome Therapeutics 12.6.1 MicroBiome Therapeutics Company Details 12.6.2 Company Description and Business Overview 12.6.3 Microbiome Drugs Introduction 12.6.4 MicroBiome Therapeutics Revenue in Microbiome Drugs Business (2013-2018) 12.6.5 MicroBiome Therapeutics Recent Development 12.7 Ritter Pharmaceuticals 12.7.1 Ritter Pharmaceuticals Company Details 12.7.2 Company Description and Business Overview 12.7.3 Microbiome Drugs Introduction 12.7.4 Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2013-2018) 12.7.5 Ritter Pharmaceuticals Recent Development 12.8 Rebiotix 12.8.1 Rebiotix Company Details 12.8.2 Company Description and Business Overview 12.8.3 Microbiome Drugs Introduction 12.8.4 Rebiotix Revenue in Microbiome Drugs Business (2013-2018) 12.8.5 Rebiotix Recent Development 12.9 OpenBiome 12.9.1 OpenBiome Company Details 12.9.2 Company Description and Business Overview 12.9.3 Microbiome Drugs Introduction 12.9.4 OpenBiome Revenue in Microbiome Drugs Business (2013-2018) 12.9.5 OpenBiome Recent Development 13 Market Forecast 2018-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2018-2025) 13.10 Market Size Forecast by Application (2018-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details
List of Tables and Figures Table Microbiome Drugs Key Market Segments Table Key Players Microbiome Drugs Covered Table Global Microbiome Drugs Market Size Growth Rate by Type 2013-2025 (Million US$) Figure Global Microbiome Drugs Market Size Market Share by Type 2013-2025 Figure Probiotics Figures Table Key Players of Probiotics Figure Prebiotics Figures Table Key Players of Prebiotics Figure Small Molecules Figures Table Key Players of Small Molecules Figure Biological Drugs Figures Table Key Players of Biological Drugs Figure Other Figures Table Key Players of Other Table Global Microbiome Drugs Market Size Growth by Application 2013-2025 (Million US$) Figure Hospital Pharmacies Case Studies Figure Retail Pharmacies Case Studies Figure Online Pharmacies Case Studies Figure Other Case Studies Figure Microbiome Drugs Report Years Considered Table Global Microbiome Drugs Market Size 2013-2025 (Million US$) Figure Global Microbiome Drugs Market Size and Growth Rate 2013-2025 (Million US$) Table Global Microbiome Drugs Market Size by Regions 2013-2025 (Million US$) Table Global Microbiome Drugs Market Size by Regions 2013-2018 (Million US$) Table Global Microbiome Drugs Market Share by Regions 2013-2018 Figure Global Microbiome Drugs Market Share by Regions 2013-2018 Figure Global Microbiome Drugs Market Share by Regions 2018 Table Market Top Trends Table Global Microbiome Drugs Revenue by Manufacturers (2013-2018) (Million US$) Table Global Microbiome Drugs Market Share by Manufacturers (2013-2018) Figure Global Microbiome Drugs Market Share by Manufacturers in 2018 Table Global Microbiome Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Microbiome Drugs Product/Solution/Service Table Date of Enter into Microbiome Drugs Market Table Mergers & Acquisitions, Expansion Plans Table Global Microbiome Drugs Market Size by Type (2013-2018) (Million US$) Table Global Microbiome Drugs Market Size Share by Type (2013-2018) Figure Global Microbiome Drugs Market Size Market Share by Type (2013-2018) Table Global Microbiome Drugs Market Size by Application (2013-2018) (Million US$) Table Global Microbiome Drugs Market Size Share by Application (2013-2018) Figure Global Microbiome Drugs Market Size Market Share by Application (2013-2018) Figure Global Microbiome Drugs Revenue Market Share by Application in 2017 Figure United States Microbiome Drugs Market Size 2013-2018 (Million US$) Table United States Key Players Microbiome Drugs Revenue (2017-2018) (Million US$) Table United States Key Players Microbiome Drugs Market Share (2017-2018) Table United States Microbiome Drugs Market Size by Type (2013-2018) (Million US$) Table United States Microbiome Drugs Market Share by Type (2013-2018) Table United States Microbiome Drugs Market Size by Application (2013-2018) (Million US$) Table United States Microbiome Drugs Market Share by Application (2013-2018) Figure Europe Microbiome Drugs Market Size 2013-2018 (Million US$) Table Europe Key Players Microbiome Drugs Revenue (2017-2018) (Million US$) Table Europe Key Players Microbiome Drugs Market Share (2017-2018) Table Europe Microbiome Drugs Market Size by Type (2013-2018) (Million US$) Table Europe Microbiome Drugs Market Share by Type (2013-2018) Table Europe Microbiome Drugs Market Size by Application (2013-2018) (Million US$) Table Europe Microbiome Drugs Market Share by Application (2013-2018) Figure China Microbiome Drugs Market Size 2013-2018 (Million US$) Table China Key Players Microbiome Drugs Revenue (2017-2018) (Million US$) Table China Key Players Microbiome Drugs Market Share (2017-2018) Table China Microbiome Drugs Market Size by Type (2013-2018) (Million US$) Table China Microbiome Drugs Market Share by Type (2013-2018) Table China Microbiome Drugs Market Size by Application (2013-2018) (Million US$) Table China Microbiome Drugs Market Share by Application (2013-2018) Figure Japan Microbiome Drugs Market Size 2013-2018 (Million US$) Table Japan Key Players Microbiome Drugs Revenue (2017-2018) (Million US$) Table Japan Key Players Microbiome Drugs Market Share (2017-2018) Table Japan Microbiome Drugs Market Size by Type (2013-2018) (Million US$) Table Japan Microbiome Drugs Market Share by Type (2013-2018) Table Japan Microbiome Drugs Market Size by Application (2013-2018) (Million US$) Table Japan Microbiome Drugs Market Share by Application (2013-2018) Figure Southeast Asia Microbiome Drugs Market Size 2013-2018 (Million US$) Table Southeast Asia Key Players Microbiome Drugs Revenue (2017-2018) (Million US$) Table Southeast Asia Key Players Microbiome Drugs Market Share (2017-2018) Table Southeast Asia Microbiome Drugs Market Size by Type (2013-2018) (Million US$) Table Southeast Asia Microbiome Drugs Market Share by Type (2013-2018) Table Southeast Asia Microbiome Drugs Market Size by Application (2013-2018) (Million US$) Table Southeast Asia Microbiome Drugs Market Share by Application (2013-2018) Figure India Microbiome Drugs Market Size 2013-2018 (Million US$) Table India Key Players Microbiome Drugs Revenue (2017-2018) (Million US$) Table India Key Players Microbiome Drugs Market Share (2017-2018) Table India Microbiome Drugs Market Size by Type (2013-2018) (Million US$) Table India Microbiome Drugs Market Share by Type (2013-2018) Table India Microbiome Drugs Market Size by Application (2013-2018) (Million US$) Table India Microbiome Drugs Market Share by Application (2013-2018) Figure Central & South America Microbiome Drugs Market Size 2013-2018 (Million US$) Table Central & South America Key Players Microbiome Drugs Revenue (2017-2018) (Million US$) Table Central & South America Key Players Microbiome Drugs Market Share (2017-2018) Table Central & South America Microbiome Drugs Market Size by Type (2013-2018) (Million US$) Table Central & South America Microbiome Drugs Market Share by Type (2013-2018) Table Central & South America Microbiome Drugs Market Size by Application (2013-2018) (Million US$) Table Central & South America Microbiome Drugs Market Share by Application (2013-2018) Table Pfizer Company Details Table Pfizer Revenue in Microbiome Drugs Business (2013-2018) (Million US$) Figure Pfizer Revenue Growth Rate in Microbiome Drugs Business (2013-2018) Table Pfizer Recent Development Table Second Genome Company Details Table Second Genome Revenue in Microbiome Drugs Business (2013-2018)(Million US$) Figure Second Genome Revenue Growth Rate in Microbiome Drugs Business (2013-2018) Table Second Genome Recent Development Table Seres Therapeutics Company Details Table Seres Therapeutics Revenue in Microbiome Drugs Business (2013-2018)(Million US$) Figure Seres Therapeutics Revenue Growth Rate in Microbiome Drugs Business (2013-2018) Table Seres Therapeutics Recent Development Table MaaT Pharma Company Details Table MaaT Pharma Revenue in Microbiome Drugs Business (2013-2018)(Million US$) Figure MaaT Pharma Revenue Growth Rate in Microbiome Drugs Business (2013-2018) Table MaaT Pharma Recent Development Table Enterome Bioscience Company Details Table Enterome Bioscience Revenue in Microbiome Drugs Business (2013-2018)(Million US$) Figure Enterome Bioscience Revenue Growth Rate in Microbiome Drugs Business (2013-2018) Table Enterome Bioscience Recent Development Table MicroBiome Therapeutics Company Details Table MicroBiome Therapeutics Revenue in Microbiome Drugs Business (2013-2018)(Million US$) Figure MicroBiome Therapeutics Revenue Growth Rate in Microbiome Drugs Business (2013-2018) Table MicroBiome Therapeutics Recent Development Table Ritter Pharmaceuticals Company Details Table Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2013-2018)(Million US$) Figure Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Drugs Business (2013-2018) Table Ritter Pharmaceuticals Recent Development Table Rebiotix Company Details Table Rebiotix Revenue in Microbiome Drugs Business (2013-2018)(Million US$) Figure Rebiotix Revenue Growth Rate in Microbiome Drugs Business (2013-2018) Table Rebiotix Recent Development Table OpenBiome Company Details Table OpenBiome Revenue in Microbiome Drugs Business (2013-2018)(Million US$) Figure OpenBiome Revenue Growth Rate in Microbiome Drugs Business (2013-2018) Table OpenBiome Recent Development Table Global Microbiome Drugs Market Size by Regions (Million US$) 2018-2025 Figure Global Microbiome Drugs Market Size Share by Regions (2018-2025) Figure Global Microbiome Drugs Market Size Share by Regions in 2025 Figure United States Microbiome Drugs Market Size Forecast (2018-2025)(Million USD) Figure Europe Microbiome Drugs Market Size Forecast (2018-2025)(Million USD) Figure China Microbiome Drugs Market Size Forecast (2018-2025)(Million USD) Figure Japan Microbiome Drugs Market Size Forecast (2018-2025)(Million USD) Figure Southeast Asia Microbiome Drugs Market Size Forecast (2018-2025)(Million USD) Figure India Microbiome Drugs Market Size Forecast (2018-2025)(Million USD) Figure Central & South America Microbiome Drugs Market Size Forecast (2018-2025)(Million USD) Table Global Microbiome Drugs Market Size by Product (2018-2025) (Million US$) Figure Global Microbiome Drugs Market Size by Product (2018-2025) Figure Global Microbiome Drugs Market Size by Product in 2025 Table Global Microbiome Drugs Market Size by Application (2018-2025) (Million US$) Figure Global Microbiome Drugs Market Size by Application (2018-2025) Figure Global Microbiome Drugs Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.